InsidersTradesSigma
Dr. Lal Pathlabs Stock: price and insider trades · India · SEBI (PIT + SAST)
Track the Dr. Lal Pathlabs share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €282.4bn. The latest transaction was disclosed on 23 June 2026 (Acquisition). Among the most active insiders: Dr. Lal PathLabs Employee Welfare Trust. The full history is accessible without an account.
31
Insider Decl.
n/a
Thresholds
€44,217
10 ops.
Buy Volume
€239,057
21 ops.
Sell Volume
52Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,552 of 26,671 companies
60.4
score / 100
Value33
Quality88
FCF yld1.6%
Earn yld1.7%
EV/EBITDA34.2x
ROE21%
Gross mgn81%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations31 total
1,474 shares@ ₹5.000.0000% mcap100.0% of flowEquity SharesESOPSEBI:348eaf869484578a03c69e40013a251bdb648b5d
Canonical exit: 21 Sept 2026 (T+90)
2,346 shares@ ₹5.000.0000% mcap0.2% of flowEquity SharesESOPSEBI:1ff6769a7dd86d32d3f69d8e9a451a53db185ce3
872 shares@ ₹5.000.0000% mcap0.2% of flowEquity SharesESOPSEBI:8ba6cccedf3d44ccf51bb5e05fdc831de4a571e2
Canonical exit: 21 Sept 2026 (T+90)
600 shares@ ₹1,651.000.0000% mcap38.4% of flowEquity SharesMarket SaleSEBI:ba5dbec5a26492fe1bb1c9e8fea272d5b2934343
1,400 shares@ ₹1,744.900.0000% mcap46.3% of flowEquity SharesMarket SaleSEBI:4de30f47658204434d27b408c59340b55e46677c
500 shares@ ₹1,087.500.0000% mcap38.6% of flowEquity SharesESOPSEBI:718566aee2a9a2e2a98873d0aacb1251b427cd69
Canonical exit: 17 Sept 2026 (T+90)
500 shares@ ₹1,792.000.0000% mcap22.2% of flowEquity SharesMarket SaleSEBI:833a7417bf9377ab21dab45f77c5aad8728c3f2f
400 shares@ ₹1,733.000.0000% mcap13.1% of flowEquity SharesMarket SaleSEBI:8b0dc71f508e0fc4a46b8e187c88aa369894e4f8
1,000 shares@ ₹1,723.000.0000% mcap60.9% of flowEquity SharesMarket SaleSEBI:175f3bae13f998eab081e78af6beeb169f304d38
1,000 shares@ ₹1,742.000.0000% mcap43.3% of flowEquity SharesMarket SaleSEBI:9886ac701ea9e7ccf0e51f055d381014ee7b62e6
500 shares@ ₹1,730.100.0000% mcap61.4% of flowEquity SharesMarket SaleSEBI:33536fe368e8189307f5d81b06990a449ab0edb6
800 shares@ ₹1,121.100.0000% mcap16.2% of flowEquity SharesESOPSEBI:a9ff3a8b0cbe7f8e5120136b1a84ef30dc932f0d
500 shares@ ₹1,690.000.0000% mcap59.7% of flowEquity SharesMarket SaleSEBI:101aa24df1831c2540d1b2f8af260662c9480653
500 shares@ ₹1,141.200.0000% mcap40.3% of flowEquity SharesESOPSEBI:74d8a418d9e1193640b413580195264a53431274
Canonical exit: 10 Sept 2026 (T+90)
1,000 shares@ ₹1,141.20100.0% of flowEquity SharesESOPSEBI:a93f27e46ef16e22d0ab0f799bc781002539ad43
Canonical exit: 27 Aug 2026 (T+90)
1,000 shares@ ₹1,621.8044.9% of flowEquity SharesMarket SaleSEBI:7262a9e4dc5f91c50c56c0ab2c195a37fb49e871
2,000 shares@ ₹5.00100.0% of flowEquity SharesESOPSEBI:35039c82d64e398291dff62fd1153ffb2cbaaa92
Canonical exit: 27 Aug 2026 (T+90)
1,250 shares@ ₹5.00100.0% of flowEquity SharesESOPSEBI:9158e24e7a119c8e131866f528238ecb72f237fd
Canonical exit: 27 Aug 2026 (T+90)
5,350 shares@ ₹318.5036.1% of flowEquity SharesESOPSEBI:c84577fc58b7fd9a118703e92ea17e47b6834731
250 shares@ ₹1,688.4035.7% of flowEquity SharesMarket SaleSEBI:777ebb83a6a2a4793d06ca78043511c665d334ef
1,000 shares@ ₹1,141.2031.8% of flowEquity SharesESOPSEBI:2e265d046a8798ce836c11eb29576b775a2827b7
Canonical exit: 23 Aug 2026 (T+90)
800 shares@ ₹1,675.8029.9% of flowEquity SharesMarket SaleSEBI:02a46a5f776a476ed430131ea46b86fef0ef1066
1,000 shares@ ₹1,141.2025.5% of flowEquity SharesESOPSEBI:e34f4d5dfe1573e92a97c18217adb07b75b6c141
Canonical exit: 23 Aug 2026 (T+90)
2,000 shares@ ₹1,141.2048.7% of flowEquity SharesESOPSEBI:e7628ef1333e90830f80bd79911bf8c28371aacb
300 shares@ ₹1,087.5027.6% of flowEquity SharesESOPSEBI:efde11a0078e226b8c8d3dc853270ca7b63bf906
Canonical exit: 23 Aug 2026 (T+90)
25 of 31 declarations
About Dr. Lal Pathlabs
Dr. Lal Pathlabs is an Indian company specializing in medical diagnostic services. It offers a wide range of laboratory tests for patients and healthcare institutions.